Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Non-Current Liabilities (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Other Non-Current Liabilities data on record, last reported at $13.7 million in Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 36.04% year-over-year to $13.7 million; the TTM value through Dec 2025 reached $13.7 million, down 36.04%, while the annual FY2025 figure was $13.7 million, 36.04% down from the prior year.
  • Other Non-Current Liabilities reached $13.7 million in Q4 2025 per PTCT's latest filing, up from $2.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $252.0 million in Q3 2021 and bottomed at $141000.0 in Q4 2023.
  • Average Other Non-Current Liabilities over 5 years is $84.0 million, with a median of $22.0 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: surged 17134.2% in 2021, then plummeted 99.92% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $239.9 million in 2021, then crashed by 98.9% to $2.6 million in 2022, then crashed by 94.66% to $141000.0 in 2023, then soared by 15095.74% to $21.4 million in 2024, then tumbled by 36.04% to $13.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $13.7 million in Q4 2025, $2.6 million in Q3 2025, and $7.8 million in Q2 2025.